Category: Screening

How can people with opioid use disorder get better virtual care?

Virtual care is the new normal around the globe. The emergence of COVID-19 introduced a dual public health emergency in British Columbia. The province was already in the fourth year of its opioid-related overdose crisis. The public health response to COVID-19 must explicitly consider different communities experiencing marginalization including persons with opioid use disorder.
(more…)

Dennis McCarty receives prestigious Kentucky award 2022

Dennis McCarty, Ph.D., an Emeritus Professor in the School of Public Health at the Portland State University and Oregon Health & Science University, has been inducted to the University of Kentucky College of Arts & Sciences Hall of Fame 2022.  This blog celebrates Dr McCarty‘s work and contribution to my research career. Please, see the event details below.

(more…)

This changed my practice

Can We Identify Patients at Risk for Opioid Use Disorder when Beginning Opioid Analgesics for Pain from New or Ongoing Non-cancer Causes?

There is growing recognition that opioid prescribing can lead to prescription opioid use disorder (OUD). It is estimated that nearly 115,000 British Columbians have become addicted to opioids. There is a need to safely reduce the volume of new opioid prescriptions for opioid naïve patients. read more…

(more…)

Hospital based opioid agonist treatment

Researchers recently found that many people with co-occurring mental health and substance use disorders are admitted to inpatient psychiatric units. According to a 2019 report from the Boston’s Institute for Healthcare Improvement and The Grayken Center, “hospitals have the opportunity to make a major impact in reducing morbidity and mortality related to opioid use.” The present study, therefore, looked at patients admitted to an acute care hospital in Vancouver, British Columbia. It sought to improve our understanding of this population and the care provided so that we can improve patients’ outcomes and care experiences.

(more…)

Boost for Oral Opioid Agonist Therapy

Although opioid agonist treatment is effective in treating opioid use disorders, retention in such treatment is suboptimal in part due to quality of care issues. A new initiative sought to boost treatment of opioid use disorders so that people stay there longer. This article describes how teams did in a structured quality improvement initiative in Vancouver, Canada. (more…)